Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas.

Liu, Junzhe; Yang, Xinyu; Ji, Qiankun; Yang, Lufei; Li, Jingying; Long, Xiaoyan; Ye, Minhua; Huang, Kai; Zhu, Xingen

Liu, Junzhe; Yang, Xinyu; Ji, Qiankun; Yang, Lufei; Li, Jingying; Long, Xiaoyan; Ye, Minhua; Huang, Kai; Zhu, Xingen.

Afiliación

Liu J; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Yang X; Institute of Neuroscience, Nanchang University, Nanchang, China.
Ji Q; Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.
Yang L; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Li J; Institute of Neuroscience, Nanchang University, Nanchang, China.
Long X; Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.
Ye M; Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Huang K; Institute of Neuroscience, Nanchang University, Nanchang, China.
Zhu X; Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.

Front Oncol ; 12: 875131, 2022.

Article en En | MEDLINE | ID: mdl-35928883

Palabras clave

PSMB9; clinical prognosis prediction; immunotherapy; lower-grade glioma (LGG); overall survival; prognostic biomarker; proteasome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google